By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Catabasis Pharmaceuticals, Inc. 

161 First Street, Suite 1A

Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-349-1971 Fax: 617-273-2637


SEARCH JOBS


Industry
Pharmaceutical






Company News
Catabasis Pharmaceuticals, Inc. Invited To Present In A Webinar Hosted By Parent Project Muscular Dystrophy 5/8/2015 11:50:11 AM
Catabasis Pharmaceuticals, Inc. Names Ted Hibben SVP, Corporate Development 4/24/2015 7:28:22 AM
Catabasis Pharmaceuticals, Inc. To Present At International Ataxia Research Conference 3/24/2015 12:18:47 PM
Catabasis Pharmaceuticals, Inc. To Present At Muscular Dystrophy Association Scientific Conference 3/10/2015 11:23:56 AM
Catabasis Pharmaceuticals, Inc. Names Rick Modi Chief Business Officer 2/6/2015 12:06:14 PM
Parent Project Muscular Dystrophy To Collaborate With Catabasis Pharmaceuticals, Inc. On CAT-1004 Development 12/11/2014 9:38:45 AM
Catabasis Pharmaceuticals, Inc. Receives FDA Orphan Drug Designation For CAT-1004 For The Treatment Of Duchenne Muscular Dystrophy 11/24/2014 9:24:13 AM
Catabasis Pharmaceuticals, Inc. Names Angelika Fretzen, Ph.D., Vice President Of Development 11/18/2014 12:21:10 PM
Catabasis Pharmaceuticals, Inc. Management To Present At October Investor Conferences 9/30/2014 10:08:06 AM
Catabasis Pharmaceuticals, Inc. To Present At International Congress Of The World Muscle Society 9/29/2014 11:57:42 AM
12345
//-->